Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | MET | P08581 | 1/20 | 0.36 |
| ▸ | TAS2R46 | P59540 | 2/20 | 0.33 |
| ▸ | PTAFR | P25105 | 1/20 | 0.33 |
| ▸ | GLI1 | P08151 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | GLI2 | P10070 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14694331 | 1.00 | PTPN1 (0.39) | PTPN1METTAS2R46PTAFRGLI1 | |
| SCHEMBL14694330 | 1.00 | PTPN1 (0.39) | PTPN1METTAS2R46PTAFRGLI1 | |
| SCHEMBL21004882 | 0.81 | TAS2R46 (0.32) | METTAS2R46 | |
| SCHEMBL21004881 | 0.81 | TAS2R46 (0.32) | METTAS2R46 | |
| SCHEMBL2902703 | 0.71 | PTPN1 (0.56) | PTPN1METTAS2R46GLI1CYP3A4 | |
| SCHEMBL2902701 | 0.71 | PTPN1 (0.56) | PTPN1METTAS2R46GLI1CYP3A4 | |
| SCHEMBL2902702 | 0.71 | PTPN1 (0.56) | PTPN1METTAS2R46GLI1CYP3A4 | |
| SCHEMBL316206 | 0.71 | PTPN1 (0.54) | PTPN1METTAS2R46PTAFRGLI1 | |
| SCHEMBL1269324 | 0.71 | PTPN1 (0.54) | PTPN1METTAS2R46PTAFRGLI1 | |
| SCHEMBL316207 | 0.71 | PTPN1 (0.54) | PTPN1METTAS2R46PTAFRGLI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2023-07-27 | — | — | US | claimed |
| US-20200345601-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2020-11-05 | — | — | US | claimed |
| EP-4632382-A2 | METHOD OF IDENTIFYING LAUNDRY MALODOR, MOLDY MALODOR AND/OR SWEAT MALODOR MODULATING COMPOUNDS | Firmenich SA (CH) | 2025-10-15 | — | — | EP | disclosed |
| EP-3883927-B1 | AMBER ODORANT | FIRMENICH & CIE (CH) | 2025-10-01 | — | — | EP | disclosed |
| US-12139469-B2 | Amber odorant | FIRMENICH SA (CH) | 2024-11-12 | — | — | US | disclosed |
| CN-111183136-B | Amber odorant | 弗门尼舍有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-11744785-B2 | Use of volatile compositions to limit or eliminate the perception of malodor | FIRMENICH SA (CH) | 2023-09-05 | — | — | US | disclosed |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2023-07-27 | — | — | US | disclosed |
| US-20220106285-A1 | AMBER ODORANT | FIRMENICH SA (CH) | 2022-04-07 | — | — | US | disclosed |
| CN-113423700-A | Amber flavor agent | 弗门尼舍有限公司 | 2021-09-21 | — | — | CN | disclosed |
| EP-3668850-B1 | AMBER ODORANT | FIRMENICH & CIE (CH) | 2021-07-14 | — | — | EP | disclosed |
| US-10889558-B2 | Amber odorant | FIRMENICH SA (CH) | 2021-01-12 | — | — | US | disclosed |
| US-20210003553-A1 | METHOD OF IDENTIFYING LAUNDRY MALODOR, MOLDY MALODOR AND/OR SWEAT MALODOR MODULATING COMPOUNDS | FIRMENICH SA (CH) | 2021-01-07 | — | — | US | disclosed |
| US-20200345601-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2020-11-05 | — | — | US | disclosed |
| US-20200299254-A1 | AMBER ODORANT | FIRMENICH SA (CH) | 2020-09-24 | — | — | US | disclosed |
| EP-3668850-A1 | AMBER ODORANT | Firmenich SA (CH) | 2020-06-24 | — | — | EP | disclosed |
| CN-111183136-A | Amber odorant | 弗门尼舍有限公司 | 2020-05-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10889558-B2 | Amber odorant | TRPA1, TAS2R41, OPRM1 | PTPN1 3190/4885MET 4825/4885TAS2R46 68/4885 |
| US-20220106285-A1 | AMBER ODORANT | OPRM1, TRPA1, PYM1 | PTPN1 3842/4885MET 4810/4885TAS2R46 77/4885 |
| US-11744785-B2 | Use of volatile compositions to limit or eliminate the perception of malodor | TAS2R8, TRPA1, TAS2R10 | PTPN1 633/4885MET 3691/4885TAS2R46 54/4885 |
| US-20200345601-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | TAS2R8, TRPA1, TAS2R10 | PTPN1 633/4885MET 3691/4885TAS2R46 54/4885 |
| US-20200299254-A1 | AMBER ODORANT | TRPA1, TAS2R41, OPRM1 | PTPN1 3190/4885MET 4825/4885TAS2R46 68/4885 |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | TAS2R8, TRPA1, TAS2R10 | PTPN1 633/4885MET 3691/4885TAS2R46 54/4885 |
| US-12139469-B2 | Amber odorant | OPRM1, TRPA1, PYM1 | PTPN1 3842/4885MET 4810/4885TAS2R46 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.